EurekAlert! -
7 Nov 2017 07:00
(Fred Hutchinson Cancer Research Center) A new category of immunotherapies called checkpoint inhibitors that has been highly effective against many different cancers appears safe to use in patients with both advanced malignancies and HIV, a population excluded from earlier trials of such therapies, according to an early-phase trial.
Share this Article